Evidence map›Paper›PMID 41153776›Full record

ArticleBiomedicines2025

Thymopentin Enhances Antitumor Immunity Through Thymic Rejuvenation and T Cell Functional Reprogramming.

Md Amir Hossain, Ye Zhang, Li Ji, Yumei Chen, Yue Luan, Yaxuan Si, Yuqing Fang, Junlan Qiu, Zhuo Wang, Guilai Liu

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Md Amir HossainCenter for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.ORCID 0000-0003-3236-6165
Ye ZhangCenter for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.
Li JiDepartment of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210002, China.
Yumei ChenCenter for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.
Yue LuanCenter for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.
Yaxuan SiCenter for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.
Yuqing FangCenter for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.
Junlan QiuDepartment of Oncology and Hematology, Suzhou Hospital, The Affiliated Hospital of Nanjing University Medical School, Suzhou 215153, China.
Zhuo WangSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Guilai LiuDepartment of Oncology and Hematology, Suzhou Hospital, The Affiliated Hospital of Nanjing University Medical School, Suzhou 215153, China.ORCID 0009-0004-6262-1838

Funding

Double First-class" Uni0020versity Project CPU2018GF10 and CPU2018GY46National Natural Science Foundation of China 82104232Natural Science Foundation of Jiangsu province BK20210428Suzhou Municipal Science and Technology Bureau SYW2025085
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancercancer immunotherapyT cell exhaustionthymopentin

Identifiers

PMID41153776
PMCPMC12561324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.